These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18566674)

  • 1. Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis.
    Holm R; de Putte GV; Suo Z; Lie AK; Kristensen GB
    Int J Med Sci; 2008 Jun; 5(3):121-6. PubMed ID: 18566674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma.
    Wu D; Suo Z; Kristensen GB; Li S; Troen G; Holm R; Nesland JM
    Gynecol Oncol; 2004 Aug; 94(2):312-9. PubMed ID: 15297167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma.
    Xu F; Zhong W; Li J; Shanshen Z; Cui J; Nesland JM; Suo Z
    Anticancer Res; 2005; 25(4):2943-50. PubMed ID: 16080548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis.
    Holm R; Knopp S; Suo Z; Tropè C; Nesland JM
    J Clin Pathol; 2007 Oct; 60(10):1086-91. PubMed ID: 17158642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.
    Han L; Dong Z; Qiao Y; Kristensen GB; Holm R; Nesland JM; Suo Z
    Gynecol Oncol; 2005 Nov; 99(2):278-86. PubMed ID: 16061279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and prognostic significance of EphA2 and EphrinA-1 in ovarian serous carcinomas].
    Han LP; Liu JF; Liu XR; Dong ZM; Suo ZH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):179-84. PubMed ID: 21500549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of EphA2 and EphrinA-1 in human gastric adenocarcinoma and its prognostic value for postoperative patients.
    Yuan WJ; Ge J; Chen ZK; Wu SB; Shen H; Yang P; Hu B; Zhang GW; Chen ZH
    Dig Dis Sci; 2009 Nov; 54(11):2410-7. PubMed ID: 19101799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expressions of angiogenesis-related factors: CD105, EphA2 and EphrinA1 in laryngeal squamous cell carcinoma and clinical implication].
    Su J; Ji XB; Xie JH; Li W
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 51(12):929-936. PubMed ID: 27978884
    [No Abstract]   [Full Text] [Related]  

  • 9. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
    Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
    Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival.
    Herath NI; Spanevello MD; Sabesan S; Newton T; Cummings M; Duffy S; Lincoln D; Boyle G; Parsons PG; Boyd AW
    BMC Cancer; 2006 Jun; 6():144. PubMed ID: 16737551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor hypoxia, p53, and prognosis in cervical cancers.
    Haensgen G; Krause U; Becker A; Stadler P; Lautenschlaeger C; Wohlrab W; Rath FW; Molls M; Dunst J
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):865-72. PubMed ID: 11429213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma.
    Straume O; Akslen LA
    Br J Cancer; 2005 Oct; 93(8):933-8. PubMed ID: 16189525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.
    Kajiyama H; Shibata K; Umezu T; Mizuno M; Suzuki S; Yamamoto E; Fujiwara S; Kikkawa F
    Hum Pathol; 2013 Feb; 44(2):181-8. PubMed ID: 22974479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
    Zhang Y; Yan M; He J; Sun J; Sun X
    J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Cytokeratin 19 and Squamous Cell Cancer Antigen in Histologically Negative Sentinel Lymph Nodes of Cervical Squamous Cell Carcinoma.
    Ren J; Zhou ZL; Xu S; Yang YJ
    Int J Gynecol Cancer; 2016 Nov; 26(9):1679-1685. PubMed ID: 27654256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Fukuchi M; Nakajima M; Kuwano H
    Int J Cancer; 2003 Feb; 103(5):657-63. PubMed ID: 12494475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
    Kristensen GB; Holm R; Abeler VM; Tropé CG
    Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome.
    Shao Z; Zhang WF; Chen XM; Shang ZJ
    Oral Oncol; 2008 Dec; 44(12):1110-7. PubMed ID: 18485799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxymethylcytosine expression is associated with poor survival in cervical squamous cell carcinoma.
    Zhang LY; Han CS; Li PL; Zhang XC
    Jpn J Clin Oncol; 2016 May; 46(5):427-34. PubMed ID: 26851753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathologic significance of laminin-5 gamma2 chain expression in cervical squamous carcinoma and adenocarcinoma.
    Andersson S; Hellström AC; Angström T; Stendahl U; Auer G; Wallin KL
    Int J Gynecol Cancer; 2005; 15(6):1065-72. PubMed ID: 16343183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.